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Abstract 17 
Objectives: The increase in infections as a result of multi-drug resistant strains of 18 
Escherichia coli is a global health crisis. The emergence of globally disseminated 19 
lineages of E. coli carrying ESBL genes has been well characterised. An increase in 20 
strains producing carbapenemase enzymes and mobile colistin resistance is now 21 
being reported, but to date there is little genomic characterisation of such strains. 22 
Methods: Routine screening of patients within an ICU of West China Hospital 23 
identified a number of E. coli carrying the blaNDM-5 carbapenemase gene, found to be 24 
two distinct clones, E. coli ST167 and ST617.  25 
Results: Interrogation of publically available data shows isolation of ESBL and 26 
carbapenem resistant strains of both lineages from clinical cases across the world. 27 
Further analysis of a large collection of publically available genomes shows that 28 
ST167 and ST617 have emerged in distinct patterns from the ST10 clonal complex 29 
of E. coli, but share evolutionary events involving switches in LPS genetics, 30 
intergenic regions and anaerobic metabolism loci.  31 
Conclusions: The identification of these lineages of E. coli and their shared genetic 32 
traits suggest there may be evolutionary events which underpin the emergence of 33 
carbapenem resistance plasmid carriage in E. coli.  34 
  35 
Introduction 36 
Infections from multi-drug resistant (MDR) Escherichia coli are a significant global 37 
health care threat.1 MDR in E. coli is largely confined to strains capable of causing 38 
extra-intestinal infections (ExPEC) such as urinary tract infections (UTI) and 39 
bacteraemia.1–4 As many as 50% of E. coli strains isolated from UTI and 40 
bacteraemia cases may exhibit resistance to three or more classes of antibiotic, 41 
termed MDR. This resistance is primarily driven by the acquisition of large plasmids 42 
containing multiple resistance genes.2 The rapid global dissemination of MDR E. coli 43 
is associated with carriage of plasmids containing genes encoding extended-44 
spectrum -lactamases (ESBL) which confer resistance to third-generation 45 
cephalosporins. 5 The carriage of MDR plasmids containing ESBL genes renders E. 46 
coli susceptible only to the carbapenem class of antibiotics and the antimicrobial 47 
compound colistin. 5 However strains of E. coli are now being reported with plasmids 48 
containing β-lactamases conferring resistance to carbapenems (carbapenemases) 49 
and the mcr-1 colistin resistance gene. 6–9 50 
The global dissemination of ESBL E. coli is attributable to the rapid dispersal of a 51 
small number of E. coli lineages. The most dominant of these is the ST131 lineage 52 
which is predominantly associated with carriage of the blaCTX-M-15 ESBL gene. 
2 53 
ST131 is an ExPEC lineage and the most common cause of UTI and bacteraemia in 54 
the developed world. 2 Other dominant lineages of ESBL E. coli are ST73, ST95, and 55 
ST648 which are also ExPEC. 3,4 ESBL carriage can also be found transiently in 56 
strains belonging the ST10 clonal complex of E. coli. 3 ST10 complex strains are 57 
host generalist E. coli which are frequently found as intestinal commensal inhabitants 58 
of mammals and avian species, 10 and are devoid of the virulence-associated genes 59 
known to be required for pathogenesis. 11 Our knowledge of the genomic landscape 60 
of carbenemase production in E. coli is far less developed, with the vast majority of 61 
reports being genomes of individual clinical isolates sporadically distributed across 62 
the globe. Just one significant publication exists reporting a specifically designed 63 
genomic analysis of a temporal collection of carbapenem resistant E. coli which 64 
showed very wide dissemination of carbepenem resistance across species and 65 
within-species lineages of the enterobacteriaceae. 12  66 
Here we report the isolation of E. coli containing the carbapenem-resistance gene 67 
blaNDM-5 in an ICU ward in West China Hospital, Chengdu. The isolates do not 68 
belong to one of the dominant MDR lineages of ExPEC, but to ST167 and ST617, 69 
both members of the ST10 clonal complex. Genomic data supports the long-term 70 
presence of these bacteria in the ICU with repeated dissemination from a central 71 
reservoir. Contextualisation of the Chinese strains with a collection of publically 72 
available genomes shows isolation of MDR ST167 and ST617 strains from clinical 73 
episodes across the world, and in the case of ST167 frequent occurrence of carriage 74 
of both ESBL and carbapenemase genes. By comparing these lineages to a large 75 
number of publically available ST10 genomes we identify potentially significant 76 
events in their evolutionary trajectories, including mutations in the LPS biosynthesis 77 
locus which truncate LPS. We also find evidence of compensatory mutations in 78 
intergenic regions as found in E. coli ST131 as well as mutations in anaerobic 79 
metabolism loci. Our findings support the need for a more concerted global 80 
surveillance effort focussing on identifying frequently occurring lineages of 81 
carbapenem resistant E. coli.  82 
Methods 83 
Bacterial isolation and characterisation 84 
Strain 0215 was recovered from a rectal swab of a 75-year-old male patient on 85 
September 2013 in a 50-bed medical ICU at West China Hospital, Chengdu, during 86 
routine screening that is performed as standard in the ICU on all new admissions. 87 
During a 7-month period from May to November 2014, blaNDM-5 positive E. coli were 88 
recovered from the rectal swabs of 8 different patients (Supplementary Table S1) 89 
from a total of 560 patients admitted to the ICU during this period. Furthermore, one 90 
of the 8 patients developed bacteraemia during his ICU stay and an E. coli was 91 
recovered from his blood and included in the study. During the study period, two 92 
additional E. coli clinical isolates carrying blaNDM-5 were recovered in the hospital, 93 
from two patients on admission. Rectal swabs were collected from patients within 2 94 
days of admission to the ICU and within the 3 days prior to ICU discharge for those 95 
patients with a length of stay of 3 days or more. Swabs were transferred to the 96 
laboratory in transport media and were screened for carbapenem-resistant 97 
Enterobacteriaceae using the CHROMAgar Orientation agar plates containing 2 98 
μg/mL meropenem.  99 
Ethics 100 
This study was conducted in accordance with the amended Declaration of Helsinki 101 
and was approved, under a waiver of consent, by the Ethics Committee of West 102 
China Hospital. Rectal swabs were collected from patients within 2 days of 103 
admission to the ICU and within the 3 days prior to ICU discharge for those patients 104 
with a length of stay of 3 days or more.  105 
Genome sequencing 106 
The ST167 and ST617 strains isolated in Chengdu were cultured in LB broth at 37oC 107 
overnight. DNA was extracted using QIAamp® DNA Mini Kit (QIAGEN) and 150 bp 108 
paired-end libraries of each strain prepared and sequenced using the Illumina HiSeq 109 
X-Ten platform (raw data accession numbers Table S2 and S3). Genomes were 110 
assembled using SPAdes 13 and annotated using Prokka. 14 The MLST sequence 111 
type of the strains was determined using the in silico prediction tool MLSTFinder. 15 112 
The E. coli genome database Enterobase (www.enterobase.warwick.ac.uk) was 113 
interrogated on 1st December 2016 and all available ST167 and ST617 genomes 114 
were downloaded (Table S2 and S3) and annotated using Prokka. A further 256 115 
ST10 genomes were selected to represent the geographical, temporal, and source 116 
attribution diversity present in the database (Table S4) and were downloaded and 117 
annotated using Prokka. To select these genomes a phylogenetic tree was inferred 118 
from the assembled genome of every ST10 on Enterobase using Parsnp. 16 From 119 
this phylogeny 500 genomes were chosen to span the entire phylogenetic diversity, 120 
and then the final selection made to represent the full ST10 diversity as described. 121 
The antibiotic resistance gene profile of all isolates was determined using Abricate 122 
(https://github.com/tseemann/abricate).  123 
High-resolution SNP analysis 124 
We created a closed genome sequence for a Chinese ST167 strain 1237 by 125 
combining our Illumina sequence data with data generated on the MinIon sequencer. 126 
Raw MinIon reads were converted into fastQ format (accession number 127 
PRJNA422975) using Poretools 17 and assembled using Canu, 18 resulting in a 128 
single contig chromosome and four distinct single contig plasmids. The raw illumina 129 
data was then used to polish the genome assembly via five iterative rounds of 130 
polishing with Pilon. 19 The ST167 and ST617 genomes from Chengdu were 131 
analysed by mapping raw reads against the hybrid assembled ST167 genome. 132 
Mapping was performed using Snippy (https://github.com/tseemann/snippy) and the 133 
resulting SNP profiles were used to create a consensus sequence for each genome 134 
which was aligned using the parsnp alignment tool in Harvest. 16  Analysis of the 135 
plasmid containing the blaNDM-5 gene revealed that it was a 47-kb IncX3 plasmid and 136 
there were no antibiotic resistant genes other than blaNDM-5 located on the plasmid. 137 
Specific mapping of the raw Illumina data against the pNDM5 plasmid was 138 
performed for all strains as described above.   139 
Phylogenetic analysis 140 
Pan-genomes were constructed for the ST167, ST617, ST10, and combined 141 
datasets using Roary 20 with the --e --mafft setting to create a concatenated 142 
alignment of core CDS. The alignments were used to infer ST167, ST617, ST10, and 143 
combined phylogenies using RaxML 21 with the GTR-Gamma model of site 144 
heterogeneity and 100 bootstrap iterations. Carriage of ESBL and carbapenemase 145 
genes was annotated on the trees using Phandango 146 
(https://jameshadfield.github.io/phandango/), and geographical source was 147 
annotated using iTOL. 22  148 
Detection of lineage specific genetic traits 149 
Microbial GWAS was performed using two approaches. First the combined data set 150 
pan-genome matrix was used as input for Scoary 23 searching for loci unique to 151 
ST167, ST617, and both ST167 and ST617 versus ST10. In parallel we also used 152 
SEER 24 to detect kmers significantly associated with ST167, ST617, or both 153 
combined versus ST10. The results of both approaches were combined to identify 154 
coding loci associated with the emergence of ST167 and ST617. In silico serotyping 155 
was performed using two independent methods, SRST2 and SerotypeFinder. 25,26 156 
Both methods utilise WGS data to specific O and H antigens to strains.  Intergenic 157 
regions (IGRs) were investigated using Piggy 27 to search for IGRs which had 158 
switched 28 in ST617, ST167, or both compared to ST10. This data was combined 159 
with SEER data to identify high-confidence IGR switches associated with the 160 
emergence of ST167 and ST617.  161 
Results 162 
Presence of E. coli ST167 and ST617 strains containing the NDM-5 163 
carbapenemase resistance gene in an ICU ward in West China Hospital. 164 
A total of ten isolates of E. coli containing blaNDM-5 were obtained during the 165 
investigation. Nine of these isolates belonged to sequence types ST167/617 (Table 166 
S1), which are members of the ST10 complex of E. coli most commonly associated 167 
with mammalian intestinal commensal carriage. Three ST167 isolates (0215, 243 168 
and 25) were obtained from swabs or clinical samples collected on admission to 169 
hospital, suggesting that they were introduced from external sources. The three 170 
patients were all citizens of Chengdu city but they were admitted to different local 171 
hospitals before transferring to West China hospital. The remaining ST167 isolates 172 
were recovered from swabs or samples collected at least 3 days after admission to 173 
the ICU of West China hospital, from patients whose initial swabs were CRE 174 
negative, indicating that they were acquired during their ICU stay. ST167 E. coli 175 
carrying blaNDM-5 caused infections (bacteremia and abdominal infection) in only two 176 
patients but colonised the others. Both ST617 E. coli carrying blaNDM-5 only colonised 177 
patients. All patients colonised or infected with E. coli carrying blaNDM-5 of ST167 or 178 
ST617 had received carbapenems before the recovery of the isolates.  179 
SNP analysis suggests continued dissemination of strains from a central 180 
reservoir and sharing of resistance plasmid between lineages. 181 
To determine the level of relatedness between all isolated strains we mapped reads 182 
of all the strains against a closed ST167 strain (strain 1237) generated by a 183 
combination of Illumina and MinIon sequence data. The resulting high-resolution 184 
SNP alignment showed the distance between the ST167 and ST617 strains to be 185 
over 25,000 SNPs, confirming they are distinct lineages, with the two ST617 isolates 186 
separated by just 7 SNPs. Deeper analysis of the ST167 cluster of strains showed 187 
diversity ranging from 5 to 799 SNPs (Fig 1). Strains 936 and 1222 (both carriage 188 
isolates) are the most closely related isolates with just 5 SNPs difference between 189 
them, with both strains being acquired by patients in the ICU within one month of 190 
each other. However these strains are 73 SNPs different from a strain isolated the 191 
exact same month on the ICU from a strain (1237) that was acquired in the ICU. This 192 
is almost double the genetic distance (46 SNPs) from a strain acquired (442 and 57, 193 
isolated from the same patient) in the ICU two months earlier. These distances are 194 
also larger than those for any isolate to the first two strains brought into the ICU, 195 
strain 0215 and strain 243, which differ from all other isolates by around 30 SNPs, 196 
and from each other by 15 SNPs.  Such an observation suggests a potential 197 
combination of patient-to-patient transmission in the affected ICU, 29 along with the 198 
continued dissemination of the strain from a central reservoir where there is an 199 
accumulation of diversity. 29,30 Genomic analysis also allows us to identify a second 200 
introgression of an ST167 strain (25) from the community, which is over 700 SNPs 201 
different from the other isolates. Mapping of the raw sequence data against the 43kb 202 
IncX3 plasmid containing blaNDM-5 also confirmed that the plasmid present in the 203 
ST617 strains was identical to that in all of the ST167 strains with just two detectable 204 
SNPs difference across the isolates.  205 
MDR ST167 and ST617 E. coli have been isolated across the world.  206 
We sought to contextualise the wider relevance of our Chengdu isolates by 207 
investigating the wider prevalence of ST167 and ST617 strains. We searched the 208 
Enterobase E. coli database and recovered a total of 87 genomes of ST167 (table 209 
S2) and 86 genomes of ST617 (table S3), isolated from across the world. A core 210 
CDS-based phylogeny of both lineages showed a diverse set of genomes with 211 
around 17,000 SNPs in ST167 and around 15,000 SNPs in ST617. Annotation of the 212 
ST617 phylogeny with lactamase gene carriage shows a high prevalence of the 213 
blaCTX-M-15 ESBL gene in characterised isolates (Fig 2A). Annotation of the ST167 214 
phylogeny with β-lactamase gene carriage (Fig 2B) shows a pattern of resistance 215 
gene carriage, with multiple independent acquisitions of carbapenemase across the 216 
phylogeny including blaNDM-1, blaNDM-5, blaNDM-7, blaOXA-181, and blaKPC-3. For both 217 
phylogenies there is clear evidence of isolation of strains from across the globe.  218 
Evolutionary genomic analysis correlates switches in LPS gene content with 219 
the emergence of the ST167/ST617 lineage 220 
Both ST167 and ST617 are single locus variants of the ST10 lineage of E. coli. ST10 221 
is the most abundant lineage of E. coli represented in the Enterobase database and 222 
contains isolates ranging from drug susceptible environmental and human 223 
commensal strains, to multi-drug resistant strains isolated from human clinical UTI 224 
and bacteraemia infections. We selected 256 ST10 genomes from Enterobase 225 
(Table S4) to represent the known spectrum of ST10 diversity present in the 226 
database, and merged this data set with our publically available ST167/ST617 227 
genome data set to create a larger ST10 complex phylogeny (Fig S1). The resulting 228 
phylogeny shows that ST167 and ST617 are sister clades with respect to ST10, with 229 
ST617 emerging as a nested clade from a single outlying ST167 genome, though 230 
the distance between ST167 and ST617 is around 18,000 SNPs.  231 
Given the phylogenetic pattern of ST167 and ST617 with respect to ST10, we sought 232 
to determine if their emergence from ST10 is associated with defined evolutionary 233 
events. We used a combined GWAS approach to compare the ST167/617 genomes 234 
with ST10, using both SEER and SCOARY analysis of a pangenome matrix. Only 235 
loci considered to be significantly associated with one lineage over the other by both 236 
methods were further investigated (Dataset S1). Most striking was the absence of 237 
the wzzB gene and wca biosynthetic cluster in ST167/ST617 whilst the majority of 238 
the ST10 genomes contained both (Figure S2). These genes are involved in LPS 239 
biosynthesis with wzzB being the master controller of O antigen chain length in the 240 
wzx/wzy pathway, whilst wca genes are responsible for colonic acid biosynthesis. 31 241 
In silico E. coli serotyping 32 established that ST167 and ST617 demonstrate the 242 
exact same O antigenic type (O32novel) with similarity also seen in H antigen type 243 
(H9 or H10) (Figure S2), whilst the  SerotypeFinder database identified the strains as 244 
O89.  245 
Our combined GWAS analysis also identified another ~90 CDS which were present 246 
across the entire data set, but which had distinct alleles in the ST167/ST617 247 
genomes compared to those in ST10 (Fig 3, Dataset S2). Many of these CDS 248 
encode dehydrogenase enzymes involved in anaerobic metabolism, or are part of 249 
the cob/pdu/eut operons known to be involved in anaerobic respiration during 250 
intestinal inflammation. 33 This would appear to suggest differential evolutionary 251 
events in key genes involved in anaerobic metabolism in the formation of the 252 
ST167/ST617 lineage. Also present were unique alleles in core CDS involved in acid 253 
and bile salt tolerance, and a number of fimbrial-like proteins. In conjunction these 254 
data would suggest differential evolutionary forces acting on loci involved in 255 
mammalian colonisation in ST167/617 in comparison to ST10. Furthermore a 256 
combined SEER and Piggy approach identified unique sequences in 17 intergenic 257 
regions (IGRs) upstream of core CDS in ST167/617 that were  distinct from ST10, 258 
including IGRs upstream of anaerobic metabolic loci also present in the 259 
SEER/SCOARY analysis (Dataset S1).  260 
Discussion 261 
Our data presented here provide a comprehensive genomic analysis of two lineages 262 
of carbapenem resistant E. coli infecting multiple patients within the ICU of West 263 
China hospital. Both these lineages, ST167 and ST617, are members of the larger 264 
ST10 complex of E. coli, which is ubiquitously found in environmental, human 265 
clinical, and mammalian intestinal commensal sampling. Our analysis is the first 266 
genome level characterisation of strains belonging to ST167 or ST617, despite a 267 
number of single site reports of clinical infections with both lineages existing in the 268 
literature.  269 
Our analysis shows that the diversity which accumulates in the genome of the ST167 270 
isolates during the course of the investigation is not mirrored by diversity in the 271 
plasmid carrying the blaNDM-5 gene. Only 1 SNP difference existed between the 272 
sequence of this plasmid in the ST167 isolates, and only 2 SNPs difference between 273 
the ST167 and ST617 isolates. As a result it is impossible to tell if the IncX3 plasmid 274 
associated with dissemination of blaNDM-5 in China 
34 was transferred between ST167 275 
and ST617 in the hospital, or if the plasmid is highly stable with only deleterious 276 
mutations occurring and quickly purged from the population. Clearly there is a need 277 
for more thorough and detailed analysis of various resistance plasmids within and 278 
between hospitals, such as was done recently for NDM-1 plasmids in Latin America. 279 
35 280 
The lack of appropriately designed isolate collection and sequencing strategy means 281 
it is impossible to conduct any form of genomic epidemiological analyses of these E. 282 
coli lineages beyond our Chinese investigation. However the ready availability of a 283 
large number of good-quality, curated genome assemblies in the Enterobase 284 
genome database do allow us to delve deeper into the evolutionary history of E. coli 285 
ST167 and ST617. Whilst data generated and uploaded to Enterobase is prone to a 286 
bias towards clinical MDR strains, it is still clear that ESBL and carbapenem resistant 287 
strains of both these lineages have been isolated from across the world over the past 288 
20 or so years (Tables S1 and S2).  289 
Comparative genomic analysis and GWAS for traits specific to ST167 and ST617 290 
compared to ST10 also support emergence along a shared evolutionary branch. Key 291 
among these is the complete loss of the wca operon encoding colanic acid 292 
biosynthesis in the LPS biosynthesis pathway. The majority of E. coli produce their 293 
LPS utilising the O-unit translocation pathway encoded for by wzx and wzy. 31 This 294 
method utilises glycosyltransferases to assemble the O antigen in units at the 295 
cytoplasmic membrane. These units are then translocated by Wzx and polymerized 296 
by Wzy until the O antigen chain length is reached. This mechanism is utilised by the 297 
majority of the ST10 isolates, however genomic analysis shows that ST167 and 298 
ST617 utilise an alternative wzm/wzt ATP transporter pathway. This biosynthetic 299 
pathway assembles the entire O-antigen on the cytoplasmic face before Wzt 300 
transports the O-chain across, 31 resulting in an O-antigen with truncated chain 301 
length. O-antigen chain length plays a major role in pathogenicity of Gram negative 302 
organisms, and it has been demonstrated that loss of long O-antigen chains in 303 
Salmonella optimizes immune evasion and allows successful colonisation. 36 304 
Alongside the LPS genetic changes, we also observed unique alleles of anaerobic 305 
metabolism genes and genes potentially involved in host colonisation in ST167/617 306 
compared to ST10. Recent modelling data has shown that any factor influencing the 307 
ability of a bacterium to colonise a host will also influence its likelihood of evolving 308 
antimicrobial resistance. 37  309 
Conclusions 310 
We provide data for the first ever, single hospital genomic analysis of clinical isolates 311 
of carbapenem resistant E. coli belonging to the ST167/617 lineage. Our data 312 
presented here provide evidence for evolutionary events that would affect microbial 313 
interaction with a mammalian host underpinning the emergence of the ST167/617 314 
lineage from ST10. There is also evidence for lineage specific alterations in 315 
intergenic regions in ST167/617, a phenomenon which has already been described 316 
as underpinning the emergence of MDR plasmid-containing E. coli ST131 strains. 28 317 
Clearly there is now a need for a fully designed genomic epidemiological 318 
investigation of lineages of E. coli associated with carriage of carbapenem resistance 319 
plasmids arising from the ST10 clade, both in China and internationally. Such a 320 
study will fully inform us of any potential parallelism in the evolution of MDR lineages 321 
of E. coli, and of the true nature and scope of their prevalence and global 322 
dissemination. 323 
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Figure 1: Maximum likelihood phylogenetic tree of E. coli ST167 strains isolated form 433 
the ICU of West China hospital. The phylogeny is inferred from a SNP alignment 434 
obtained by mapping raw data against a MinIon/Illumina hybrid complete assembly 435 
of isolate 1237.  The annotation denotes the presence of ESBL and CPE associated 436 
-lactamases as determined by Abricate.  437 
 438 
Figure 2: Maximum likelihood phylogenetic trees of a global collection of (A) ST617 439 
and (B) ST167 strains. The phylogeny is inferred from an alignment of concatenated 440 
core CDS sequences as determined by Roary, and is mid-point rooted. The 441 
annotation denotes the presence of ESBL and CPE associated -lactamases as 442 
determined by Abricate.  443 
 444 
Figure 3: Manhattan skyline plot showing position of kmers identified by GWAS 445 
analysis as being significantly associated with ST167/617 compared to ST10. The x 446 
axis indicates the position on the WCHEC1237 complete genome assembly, whilst 447 
the Y axis indicates the numbers of statistically significant kmers mapping at that 448 
position. Hits indicated in red are either intergenic regions (labelled IGR) identified as 449 
being unique by both Piggy and SEER analysis, or anaerobic metabolism loci 450 
identified as significantly different by both SEER and Scoary.  451 
 452 
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